Literature DB >> 12777691

Rapid single-base mismatch detection in genotyping for phenylketonuria.

Yutaka Takarada1, Shohei Kagawa, Yoshiyuki Okano, Takakuni Tanizawa.   

Abstract

Phenylketonuria (PKU) is a metabolic disorder that results from a deficiency of hepatic phenylalanine hydroxylase (PAH). Identification of the PKU genotype is useful for predicting clinical PKU phenotype. More than 400 mutations resulting in PAH deficiency have been reported worldwide. We used a genedetecting instrument to identify the nine prevalent Japanese mutations in the PAH gene among 31 PKU patients as a preliminary study. This instrument can automatically detect mutations through the use of allelespecific oligonucleotide (ASO) capture probes, and gave results comparable to those of sequencing studies. Each country has uniquely prevalent and specific mutations causing PKU, and less than 50 types of such mutations are generally present in each country. Early genotyping of PKU makes it possible to identify the phenotype and select the optimal therapy for the disease. For early genotyping, the instrumental method described here shortens the time required for genotyping based on mRNA and/or genomic DNA of PKU parents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12777691     DOI: 10.1385/MB:24:3:233

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  24 in total

1.  Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase.

Authors:  S C Kwok; F D Ledley; A G DiLella; K J Robson; S L Woo
Journal:  Biochemistry       Date:  1985-01-29       Impact factor: 3.162

2.  Molecular characterization of phenylketonuric mutations in Japanese by analysis of phenylalanine hydroxylase mRNA from lymphoblasts.

Authors:  Y Okano; Y Hase; H Shintaku; K Araki; J Furuyama; T Oura; G Isshiki
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

3.  Analysis of the phenylalanine hydroxylase gene in the Spanish population: mutation profile and association with intragenic polymorphic markers.

Authors:  B Pérez; L R Desviat; M Ugarte
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

4.  Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations.

Authors:  E Kayaalp; E Treacy; P J Waters; S Byck; P Nowacki; C R Scriver
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

5.  Amplification of phenylalanine hydroxylase and cystathionine beta-synthase transcripts in human peripheral lymphocytes by RT-PCR.

Authors:  K S Devi; A R Devi; P Kondaiah
Journal:  Biochem Mol Biol Int       Date:  1998-07

6.  Phenylketonuria genotypes correlated to metabolic phenotype groups in Norway.

Authors:  H G Eiken; P M Knappskog; K Motzfeldt; H Boman; J Apold
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

7.  Illegitimate transcription of phenylalanine hydroxylase for detection of mutations in patients with phenylketonuria.

Authors:  S J Ramus; S M Forrest; R G Cotton
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

8.  Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction.

Authors:  A G DiLella; W M Huang; S L Woo
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

9.  Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria.

Authors:  S L Woo; A S Lidsky; F Güttler; T Chandra; K J Robson
Journal:  Nature       Date:  1983 Nov 10-16       Impact factor: 49.962

10.  Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene.

Authors:  Y Okano; T Wang; R C Eisensmith; B Steinmann; R Gitzelmann; S L Woo
Journal:  Am J Hum Genet       Date:  1990-01       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.